Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30,942
Closed -$61.6K 1232
2025
Q2
$61.6K Buy
+30,942
New +$56.6K ﹤0.01% 927

Quadrature Capital's HLVX Position: Q3 2025 in Review

Quadrature Capital sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 30,942 shares — an estimated $61.6K sold.

Quadrature Capital first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $61.6K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Quadrature Capital reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Quadrature Capital sold 30,942 HilleVax shares in Q3 2025, an estimated $61.6K.
  • Quadrature Capital first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
  • Quadrature Capital's HilleVax position peaked at $61.6K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.